HLTH:AU:AU-VanEck Global Healthcare Leaders ETF (AUD)

ETF | Others |

Last Closing

USD 10.96

Change

0.00 (0.00)%

Market Cap

USD 0.06B

Volume

6.97K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-17 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
VAS:AU Vanguard Australian Shares

+0.30 (+0.32%)

USD 14.72B
IVV:AU iShares Core S&P 500 AUD

+0.36 (+0.69%)

USD 7.65B
VGS:AU Vanguard MSCI International Sh..

+0.78 (+0.65%)

USD 7.36B
QUAL:AU VanEck Vectors MSCI World ex A..

+0.25 (+0.47%)

USD 5.58B
IOZ:AU Ishares Core S&P/Asx 200

+0.11 (+0.36%)

USD 5.44B
STW:AU SPDR® S&P/ASX 200 Fund

+0.24 (+0.35%)

USD 5.14B
NDQ:AU Betashares Nasdaq 100

+0.30 (+0.73%)

USD 4.86B
HNDQ:AU BetaShares NASDAQ 100 ETF - Cu..

-0.07 (-0.19%)

USD 4.86B
A200:AU BetaShares Australia 200

+0.47 (+0.37%)

USD 4.72B
VTS:AU Vanguard US Total Market Share..

+2.60 (+0.68%)

USD 3.95B

ETFs Containing HLTH:AU

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.51% 66% D+ 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.51% 62% D 67% D+
Trailing 12 Months  
Capital Gain 1.67% 36% F 63% D
Dividend Return 1.02% 11% F 7% C-
Total Return 2.69% 23% F 59% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -1.02% 28% F 41% F
Dividend Return -0.78% 20% F 38% F
Total Return 0.23% 4% F 4% F
Risk Return Profile  
Volatility (Standard Deviation) 8.17% 77% C+ 95% A
Risk Adjusted Return -9.56% 20% F 34% F
Market Capitalization 0.06B 14% F 51% F

Annual Financials (AUD)

Quarterly Financials (AUD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.